B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

activated TAK1 mediates p38 MAPK activation

REACTOME PATHWAY
Reactome: R-HSA-45030210 genes41 compounds

The activated TAK1 mediates p38 MAPK activation pathway (Reactome ID: R-HSA-450302) involves 10 genes and is affected by 41 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

IRAK1MAP2K3MAP3K7MAPK11MAPK14MAPKAPK2NOD1NOD2RIPK2UBE2N

Compounds Affecting activated TAK1 mediates p38 MAPK activation

#CompoundTargets HitStudies
1Sorafenib300
2Afatinib297
3Anisomycin247
4Crizotinib298
5Dasatinib299
6isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
7withaferin300
8Camptothecin300
9Digitoxin300
10Digoxin299
11Ouabain300
12Oxyphenbutazone300
13Axitinib298
14cycloheximide300
15Adenosine Triphosphate300
16egcg300
17fisetin78
18myricetin-3-O-galactopyranoside [Supplementary Concept]300
19Quercetin300
20Celecoxib295
21tyrphostin ag 14784
22Calcimycin216
23Calcitriol300
24cardamonin180
25dihydrorotenone13
26Disulfiram297
27Hexachlorophene300
28Tripterygium300
29naringin300
30Chlorhexidine299
31Perphenazine297
32Sphingosine300
33Resveratrol298
34Sertraline1,000
35Astemizole Antihistamine drug now withdrawn from280
36Canrenone300
37Thioridazine35
38Vemurafenib298
39Adenosine298
40Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate).300
41alsterpaullone12

About the activated TAK1 mediates p38 MAPK activation Pathway

The activated TAK1 mediates p38 MAPK activation pathway is catalogued in Reactome (ID: R-HSA-450302) and involves 10 genes. In the BiohacksAI corpus, 41 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include IRAK1, MAP2K3, MAP3K7, MAPK11, MAPK14.